Loading...

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity

Senicapoc, a Gardos channel inhibitor, prevented erythrocyte dehydration in clinical trials of patients with sickle cell disease. We tested the hypothesis that senicapoc-induced blockade of the Gardos channel inhibits Plasmodium growth. Senicapoc inhibited in vitro growth of human and primate plasmo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Tubman, Venée N., Mejia, Pedro, Shmukler, Boris E., Bei, Amy K., Alper, Seth L., Mitchell, James R., Brugnara, Carlo, Duraisingh, Manoj T.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704178/
https://ncbi.nlm.nih.gov/pubmed/26459896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01668-15
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!